Other aspects Carnitine is widely involved in Ca 2+ signaling in a variety of biological processes [118]
Lambert, S
P., Jain, R., Bhanushali, N., & Bhatnagar, V

Baseline characteristics play a significant role: Starting weight and BMI : Individuals with higher baseline body weight may experience more absolute weight loss initially Metabolic rate : Basal metabolic rate varies with age, sex, muscle mass, and genetic factors Insulin resistance severity : Those with greater insulin resistance may respond differently Concurrent medications : Some drugs (e.g., corticosteroids, certain antipsychotics) may counteract weight loss Lifestyle factors are equally important: Dietary adherence : Calorie intake and nutritional quality significantly impact results Physical activity levels : Regular exercise enhances weight loss and improves metabolic health Sleep quality : Poor sleep is associated with weight gain and reduced treatment efficacy Stress management : Chronic stress and elevated cortisol can impede weight loss Treatment-related factors include: Dose achieved : Higher doses (14 mg) generally produce greater weight loss than lower doses Treatment duration : Longer treatment periods typically yield more substantial results Tolerability : Gastrointestinal side effects may limit dose escalation in some patients Adherence : Consistent daily dosing is essential for optimal outcomes Additionally, underlying medical conditions such as hypothyroidism, polycystic ovary syndrome, or other endocrine disorders may influence weight loss velocity

At the same time, in LEADER, the therapys effectiveness was not impacted by the presence or absence of CHF
Taking doses closer than the recommended 2-day minimum interval could theoretically increase drug exposure beyond intended levels, potentially intensifying these gastrointestinal symptoms